NEW YORK (GenomeWeb News) — Both of the currently marketed next-gen sequencers — 454’s GS 20 and Solexa’s 1G Genome Analyzer — use sequencing-by-synthesis to read the DNA. But sequencing technologies based on new variations on this theme are starting to crop up.
 
One developer of such a technology is Mike Metzker, whose research group at Baylor College of Medicine’s Human Genome Sequencing Center has been developing a reversible terminator chemistry for SBS sequencing and is currently demonstrating its ability to read DNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.